Abstract:Background: Metabolites in plasma form biosignatures of a range of common complex human diseases. Mapping the genetic architecture and discovering variants with pleiotropic effects across metabolites can reveal underlying mechanisms and potential targets for personalized interventions. Methods: We performed univariate and multivariate genome-wide association studies (GWAS) on the Nightingale panel of 249 circulating plasma metabolic markers, across 207,836 White British UK Biobank participants (mean age 57.4 years, 53.7% female), with replication conducted across 27,509 UK Biobank participants with different ancestries, and 92,661 Estonian Biobank participants (mean age 50.9 years, 65.7% female). We investigated rare variation through whole exome sequencing gene burden tests, quantified genetic architectures through Gaussian mixture modelling, analysed the causal role of body mass index (BMI) through Mendelian randomization, and performed genome-wide interaction analyses with sex. Results: We discovered 14,837 loci (497 unique), with shared and distinct effects on cardiometabolic traits, with high replication rates across populations. The loci explained over 70% of genetic variance for fatty acids. Findings from common and rare variant gene tests converged on lipid homeostasis pathways. There was strong evidence for causal effects of BMI on cholesterol and amino acid levels. We discovered 31 loci interacting with sex, which mapped to genes involved in cholesterol processing, and to cardiometabolic conditions with sex differences in prevalence. Discussion: The findings offer new insights into the genetic architecture of circulating metabolites, revealing novel loci and plausible sex-specific molecular mechanisms of lipid metabolism. This improved understanding of the molecular biology of metabolism lays a foundation for personalized prevention and treatment strategies.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the pleiotropy and sex - specific genetic architecture of circulating metabolic markers. Specifically, the study aims to identify common and rare variants that affect circulating metabolic markers through genome - wide association studies (GWAS), and to explore the pleiotropic effects of these variants, as well as the effects of sex and body mass index (BMI) on these metabolic markers. The study also attempts to reveal the causal relationship between obesity and metabolite levels, and the sex - specific molecular mechanisms in the metabolic process, thereby providing a basis for personalized prevention and treatment strategies. ### Main research questions: 1. **Identify genetic variants affecting circulating metabolic markers**: Through univariate and multivariate GWAS, identify genetic loci associated with 249 circulating plasma metabolic markers. 2. **Explore pleiotropic effects**: Analyze whether these genetic variants have a broad impact on multiple metabolic markers. 3. **Sex - specific effects**: Study how sex affects the genetic architecture of these metabolic markers and identify sex - specific genetic loci. 4. **Causal relationship of obesity**: Through Mendelian Randomization method, evaluate the causal impact of BMI on metabolite levels. 5. **Impact of rare variants**: Through whole - exome sequencing data, study the impact of rare variants on metabolic markers. ### Research background: - **Importance of metabolites**: Circulating metabolites are important biomarkers for many common and complex human diseases, and reliable quantification of the concentrations of these metabolites is crucial for understanding metabolic processes and disease mechanisms. - **Technological progress**: The development of high - throughput nuclear magnetic resonance (NMR) spectroscopy technology has made it possible to accurately measure metabolites in large - scale population samples. - **Complexity of genetic architecture**: The genetic correlations between metabolites indicate that joint analysis of these metabolites may help to discover genetic variants with broad effects. ### Research methods: - **GWAS**: Conduct univariate and multivariate GWAS on 207,836 white British UK Biobank participants, and use NMR data to detect 249 circulating metabolic markers. - **Multivariate analysis**: Use the Multivariate Omnibus Statistical Test (MOSTest) method to identify genetic variants with pleiotropic effects. - **Rare variant analysis**: Through whole - exome sequencing data, conduct gene - burden tests to study the impact of rare variants. - **Effects of sex and BMI**: Through linear regression analysis and Mendelian Randomization method, evaluate the effects of sex and BMI on metabolite levels. ### Research results: - **Discovery of a large number of genetic loci**: A total of 14,837 genetic loci were discovered, of which 497 were unique, and these loci had a high replication rate in different populations. - **Significant pleiotropic effects**: Many genetic variants have a broad impact on multiple metabolic markers. - **Sex - specific effects**: 31 genetic loci interacting with sex were discovered, which are mainly involved in cholesterol processing and metabolic conditions with obvious sex differences. - **Causal effect of BMI**: BMI has a significant causal impact on cholesterol and amino acid levels. ### Discussion: - **New genetic insights**: The study provides new insights into the genetic architecture of circulating metabolic markers, revealing new genetic loci and sex - specific molecular mechanisms. - **Basis for personalized medicine**: These findings lay the basis for personalized prevention and treatment strategies, especially in the management of cardiometabolic diseases and obesity. Through these studies, scientists can better understand the genetic basis of metabolic processes and provide important scientific basis for future precision medicine.

Pleiotropic and sex-specific genetic architecture of circulating metabolic markers

An Atlas of Genetic Influences on Human Blood Metabolites

Rare and common genetic determinants of metabolic individuality and their effects on human health

Genome-wide association study for circulating metabolites in 619,372 individuals

Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations

Genetic Architecture and Analysis Practices of Circulating Metabolites in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program

Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases

Longitudinal analysis of genetic and environmental interplay in human metabolic profiles and the implication for metabolic health

Novel genetic associations with serum level metabolites identified by phenotype set enrichment analyses.

Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers

Genome-wide association and Mendelian randomization analysis prioritizes bioactive metabolites with putative causal effects on common diseases

A cross-platform approach identifies genetic regulators of human metabolism and health

Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank

An interaction map of circulating metabolites, immune gene networks, and their genetic regulation

Ranking and characterization of established BMI and lipid associated loci as candidates for gene-environment interactions

Age- and sex-specific causal effects of adiposity on cardiovascular risk factors

Gene networks and pathways for plasma lipid traits via multitissue multiomics systems analysis

Methylome-wide studies of six metabolic traits

Genotype-based "virtual" metabolomics in a clinical biobank identifies novel metabolite-disease associations

Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease

Metabolomic signatures of lipid-modifying therapies using drug target Mendelian randomization